First Header Logo Second Header Logo

Steven Feldman

Concepts (1170)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Psoriasis
325
2021
360
79.800
Why?
Dermatologic Agents
189
2021
229
49.590
Why?
Dermatology
116
2021
163
28.380
Why?
Dermatitis, Atopic
72
2020
102
23.300
Why?
Acne Vulgaris
75
2021
96
23.030
Why?
Skin Diseases
85
2021
142
20.710
Why?
Medication Adherence
73
2020
161
20.400
Why?
Biological Products
47
2021
77
16.550
Why?
Rosacea
38
2019
45
16.060
Why?
Humans
819
2021
32114
15.530
Why?
Antibodies, Monoclonal
44
2020
246
11.130
Why?
Glucocorticoids
39
2019
146
10.810
Why?
Anti-Inflammatory Agents
39
2020
99
10.510
Why?
Severity of Illness Index
130
2020
881
10.370
Why?
Patient Compliance
47
2020
225
10.140
Why?
Skin Neoplasms
45
2020
214
9.190
Why?
Ultraviolet Therapy
34
2019
40
9.010
Why?
Phototherapy
35
2020
52
8.490
Why?
United States
197
2021
3976
8.350
Why?
Administration, Topical
84
2020
140
7.950
Why?
Administration, Cutaneous
75
2020
116
7.940
Why?
Physician-Patient Relations
38
2019
185
7.910
Why?
Treatment Outcome
135
2021
3306
7.830
Why?
Quality of Life
80
2021
946
7.770
Why?
Adrenal Cortex Hormones
30
2020
122
7.630
Why?
Anti-Bacterial Agents
35
2020
324
7.520
Why?
Skin
29
2020
211
7.450
Why?
Adult
249
2021
9380
7.420
Why?
Health Care Costs
34
2020
118
7.350
Why?
Female
320
2021
20015
7.200
Why?
Male
306
2021
19217
7.070
Why?
Patient Satisfaction
37
2020
240
7.040
Why?
Middle Aged
224
2021
11839
6.660
Why?
Health Care Surveys
60
2020
185
6.650
Why?
Patient Education as Topic
34
2019
272
6.390
Why?
Office Visits
39
2017
73
6.150
Why?
Retinoids
27
2019
41
5.960
Why?
Adolescent
136
2020
3568
5.800
Why?
Ambulatory Care
33
2018
108
5.740
Why?
Desoximetasone
10
2020
10
5.670
Why?
Clobetasol
21
2020
26
5.630
Why?
Immunosuppressive Agents
29
2020
240
5.040
Why?
Young Adult
88
2020
2665
5.000
Why?
Methotrexate
28
2020
64
4.980
Why?
Calcitriol
18
2020
25
4.910
Why?
Immunologic Factors
22
2021
49
4.790
Why?
Practice Guidelines as Topic
32
2020
408
4.740
Why?
Clinical Trials as Topic
39
2019
301
4.530
Why?
Benzoyl Peroxide
16
2021
19
4.500
Why?
Keratolytic Agents
24
2018
29
4.390
Why?
Drug Costs
22
2020
47
4.270
Why?
Keratosis, Actinic
11
2021
20
4.150
Why?
Acitretin
17
2018
18
4.080
Why?
Arthritis, Psoriatic
20
2019
25
4.080
Why?
Dermatitis, Allergic Contact
10
2019
14
4.040
Why?
Child
85
2020
2442
3.880
Why?
Aged
134
2021
10314
3.870
Why?
Drug Prescriptions
17
2017
54
3.770
Why?
Health Expenditures
11
2020
66
3.650
Why?
Internship and Residency
12
2019
313
3.410
Why?
Betamethasone
12
2020
53
3.390
Why?
Internet
17
2019
198
3.270
Why?
Retrospective Studies
67
2020
3510
3.240
Why?
Erythema
11
2019
26
3.220
Why?
Cost-Benefit Analysis
38
2018
186
3.090
Why?
Nicotinic Acids
7
2020
8
3.060
Why?
Depression
17
2021
445
2.960
Why?
Drug Monitoring
14
2019
27
2.840
Why?
Pruritus
14
2020
47
2.820
Why?
Ultraviolet Rays
16
2020
51
2.800
Why?
Boron Compounds
6
2020
11
2.770
Why?
Randomized Controlled Trials as Topic
28
2021
510
2.770
Why?
Drug Therapy, Combination
33
2019
288
2.760
Why?
Biological Factors
7
2020
11
2.740
Why?
Drug Utilization
15
2018
49
2.640
Why?
Facial Dermatoses
9
2019
18
2.640
Why?
Thalidomide
7
2019
31
2.640
Why?
Immunoglobulin G
20
2013
122
2.630
Why?
Cost of Illness
17
2020
70
2.600
Why?
Insurance, Health
12
2020
95
2.560
Why?
Patient Acceptance of Health Care
11
2020
172
2.550
Why?
Communication
11
2019
142
2.520
Why?
Patient Preference
13
2019
47
2.500
Why?
Naphthalenes
8
2021
40
2.470
Why?
Home Care Services
7
2020
51
2.470
Why?
Tumor Necrosis Factor-alpha
14
2019
210
2.450
Why?
Administration, Oral
25
2019
187
2.420
Why?
Self Care
10
2019
144
2.410
Why?
Child, Preschool
44
2020
1270
2.340
Why?
Prevalence
38
2021
989
2.340
Why?
Comorbidity
23
2020
566
2.330
Why?
Databases, Factual
25
2020
355
2.330
Why?
Prescription Drugs
6
2020
19
2.280
Why?
Biological Therapy
9
2020
20
2.260
Why?
Double-Blind Method
27
2021
525
2.250
Why?
Scalp Dermatoses
6
2016
18
2.210
Why?
Sunbathing
5
2018
6
2.200
Why?
Receptors, Tumor Necrosis Factor
20
2013
46
2.170
Why?
Quality of Health Care
9
2018
147
2.130
Why?
Drug Administration Schedule
27
2019
276
2.080
Why?
Ambulatory Surgical Procedures
12
2013
27
2.050
Why?
Antirheumatic Agents
12
2020
29
2.050
Why?
Oxymetazoline
4
2019
4
2.010
Why?
PUVA Therapy
19
2017
22
2.000
Why?
Publishing
4
2020
60
1.980
Why?
Drug Design
8
2020
43
1.930
Why?
Anti-Infective Agents
7
2017
44
1.920
Why?
Interleukin-17
5
2019
26
1.880
Why?
Biopsy
8
2019
259
1.860
Why?
Tretinoin
8
2014
34
1.860
Why?
Eczema
7
2020
13
1.830
Why?
Drug Combinations
17
2021
98
1.820
Why?
Hand Dermatoses
6
2010
10
1.780
Why?
Age Factors
31
2020
1189
1.780
Why?
Pyrroles
8
2018
55
1.760
Why?
Risk Assessment
27
2019
1429
1.750
Why?
Agricultural Workers' Diseases
15
2013
85
1.750
Why?
Pyrimidines
8
2018
65
1.740
Why?
Metronidazole
8
2017
15
1.740
Why?
Inflammatory Bowel Diseases
3
2018
29
1.700
Why?
Sunscreening Agents
6
2020
13
1.690
Why?
Medicare
19
2020
206
1.670
Why?
Lymphoma
5
2018
35
1.620
Why?
Anti-Inflammatory Agents, Non-Steroidal
5
2019
72
1.620
Why?
Periodicals as Topic
5
2020
91
1.600
Why?
Isotretinoin
7
2014
12
1.580
Why?
Aged, 80 and over
37
2020
3990
1.580
Why?
Time Factors
27
2020
2151
1.570
Why?
Skin Care
5
2019
13
1.550
Why?
Pain
10
2020
288
1.550
Why?
Evidence-Based Medicine
18
2021
218
1.530
Why?
Fluorouracil
4
2020
81
1.520
Why?
Pediatrics
9
2020
155
1.500
Why?
Bibliometrics
3
2020
11
1.500
Why?
Drug Industry
5
2019
17
1.490
Why?
Cosmetic Techniques
4
2018
11
1.480
Why?
Pyoderma Gangrenosum
4
2017
12
1.480
Why?
Physician's Role
6
2017
40
1.480
Why?
Carcinoma, Basal Cell
10
2015
26
1.460
Why?
Cyclosporine
11
2020
49
1.430
Why?
Infant
28
2020
1062
1.420
Why?
Piperidines
8
2018
118
1.410
Why?
Tacrolimus
8
2018
65
1.380
Why?
Caregivers
6
2019
114
1.380
Why?
Goals
2
2020
36
1.370
Why?
Gels
11
2017
31
1.370
Why?
Sex Factors
21
2020
667
1.370
Why?
Mohs Surgery
9
2020
16
1.360
Why?
Tuberculosis
5
2020
15
1.350
Why?
Small Molecule Libraries
3
2017
11
1.340
Why?
Interleukin-23 Subunit p19
2
2019
11
1.330
Why?
Patient Selection
9
2015
276
1.320
Why?
Hyperlipidemias
3
2018
54
1.320
Why?
Fingers
3
2019
64
1.320
Why?
Registries
8
2021
298
1.320
Why?
Recombinant Fusion Proteins
10
2013
105
1.320
Why?
Ethnic Groups
8
2020
476
1.310
Why?
Triamcinolone
5
2018
11
1.310
Why?
Clindamycin
4
2014
22
1.300
Why?
Salicylic Acid
5
2013
6
1.280
Why?
Wound Healing
7
2018
185
1.260
Why?
Cross-Sectional Studies
28
2020
1542
1.250
Why?
Health Resources
3
2018
33
1.240
Why?
Dermatitis
9
2019
21
1.230
Why?
Arthritis, Rheumatoid
3
2018
40
1.230
Why?
Behavior, Addictive
4
2009
32
1.230
Why?
Drug Packaging
3
2020
6
1.230
Why?
Lasers, Excimer
4
2012
8
1.220
Why?
Delivery of Health Care
8
2017
161
1.220
Why?
Carcinoma, Squamous Cell
9
2015
154
1.200
Why?
Animals
27
2020
7542
1.200
Why?
Vitamin D
8
2020
184
1.200
Why?
Keratosis
7
2016
23
1.170
Why?
Foot Dermatoses
5
2009
9
1.170
Why?
Primary Health Care
6
2017
227
1.150
Why?
Doxycycline
4
2017
26
1.150
Why?
Dose-Response Relationship, Drug
16
2019
633
1.150
Why?
Dermatitis, Contact
6
2014
11
1.140
Why?
Physicians
9
2018
159
1.140
Why?
Antifungal Agents
5
2015
40
1.130
Why?
Attitude of Health Personnel
5
2014
184
1.120
Why?
Transients and Migrants
17
2013
297
1.120
Why?
Hypothyroidism
2
2016
12
1.110
Why?
Patient Care Planning
3
2020
58
1.110
Why?
Biomedical Research
4
2019
156
1.100
Why?
Coronavirus Infections
4
2020
99
1.100
Why?
Melanoma
8
2017
164
1.100
Why?
Pneumonia, Viral
4
2020
103
1.100
Why?
Dermatitis, Occupational
5
2019
10
1.080
Why?
Reminder Systems
2
2018
22
1.080
Why?
Medicine
7
2020
38
1.080
Why?
Ointments
13
2020
24
1.060
Why?
Melanosis
7
2010
15
1.050
Why?
Models, Economic
8
2018
20
1.040
Why?
Emollients
8
2017
11
1.030
Why?
Fluocinonide
5
2019
11
1.030
Why?
Onychomycosis
4
2019
8
1.030
Why?
Ivermectin
4
2018
9
1.020
Why?
Insurance Coverage
7
2017
75
1.020
Why?
Dicarboxylic Acids
4
2017
7
1.010
Why?
Cardiovascular Diseases
8
2018
1128
1.010
Why?
Hyperpigmentation
4
2018
17
1.000
Why?
Health Knowledge, Attitudes, Practice
6
2017
357
1.000
Why?
Protein Kinase Inhibitors
6
2018
85
1.000
Why?
Contraceptives, Oral, Combined
2
2017
6
0.990
Why?
Beauty Culture
5
2009
7
0.990
Why?
Drug Compounding
8
2019
36
0.990
Why?
Hispanic Americans
21
2014
940
0.990
Why?
Managed Care Programs
8
2014
41
0.980
Why?
Hospitalization
11
2020
470
0.970
Why?
Prednisone
4
2012
61
0.970
Why?
Photography
4
2020
44
0.960
Why?
Telemedicine
4
2021
102
0.960
Why?
Scalp
5
2020
38
0.960
Why?
Specialties, Surgical
3
2013
28
0.960
Why?
Placebo Effect
4
2017
14
0.960
Why?
Off-Label Use
6
2020
12
0.950
Why?
Utilization Review
2
2019
17
0.950
Why?
Tetracycline
4
2014
13
0.950
Why?
Cicatrix
3
2015
39
0.950
Why?
Treatment Refusal
4
2007
11
0.930
Why?
Hot Temperature
5
2014
71
0.930
Why?
Nonprescription Drugs
5
2015
23
0.930
Why?
Clinical Trials, Phase III as Topic
7
2020
30
0.930
Why?
Combined Modality Therapy
15
2019
560
0.930
Why?
Allergens
2
2019
15
0.930
Why?
Depressive Disorder
3
2018
75
0.930
Why?
Health Services Accessibility
5
2017
242
0.930
Why?
Continental Population Groups
4
2020
237
0.930
Why?
Pharmaceutical Preparations
2
2019
36
0.920
Why?
Health Promotion
3
2018
258
0.910
Why?
Risk
4
2018
321
0.910
Why?
Medicaid
9
2020
94
0.910
Why?
Interleukin-23
4
2019
21
0.900
Why?
Transcutaneous Electric Nerve Stimulation
2
2019
9
0.900
Why?
Pathology
3
2009
17
0.890
Why?
Vasoconstriction
4
2017
43
0.880
Why?
Follow-Up Studies
20
2018
2265
0.880
Why?
Risk Factors
26
2021
3880
0.880
Why?
Disease Management
5
2018
126
0.880
Why?
Reimbursement, Incentive
2
2015
11
0.870
Why?
Monitoring, Physiologic
3
2020
73
0.870
Why?
Cost Control
3
2020
18
0.870
Why?
Azetidines
2
2020
10
0.870
Why?
Dermoscopy
2
2013
12
0.870
Why?
Attitude to Health
6
2019
166
0.860
Why?
Laser Therapy
7
2019
55
0.860
Why?
Burns
2
2014
100
0.860
Why?
Counseling
3
2020
97
0.860
Why?
Sickness Impact Profile
9
2015
35
0.850
Why?
Video Recording
2
2013
59
0.840
Why?
Tetracyclines
2
2019
2
0.840
Why?
Sulfonamides
2
2020
67
0.840
Why?
Vitiligo
3
2019
4
0.820
Why?
Research Design
7
2015
315
0.820
Why?
Quality Assurance, Health Care
3
2009
72
0.820
Why?
Surgery, Plastic
5
2013
27
0.820
Why?
Ethics, Medical
2
2020
18
0.820
Why?
Drugs, Generic
5
2020
15
0.800
Why?
Vasoconstrictor Agents
2
2019
61
0.800
Why?
Hypertension
3
2018
960
0.800
Why?
Treatment Failure
8
2018
162
0.800
Why?
Autoimmune Diseases
3
2018
48
0.790
Why?
Guidelines as Topic
2
2020
47
0.790
Why?
Equipment and Supplies
2
2020
16
0.790
Why?
Petrolatum
2
2020
4
0.790
Why?
Prescription Fees
2
2016
6
0.790
Why?
Adolescent Behavior
2
2020
61
0.780
Why?
Cryosurgery
4
2015
20
0.780
Why?
United States Food and Drug Administration
7
2019
50
0.770
Why?
Education, Distance
1
2021
19
0.770
Why?
Budgets
2
2018
10
0.760
Why?
Pilot Projects
11
2018
548
0.760
Why?
Obesity
9
2018
1176
0.760
Why?
Surgical Procedures, Operative
5
2010
84
0.750
Why?
Self Concept
5
2015
43
0.750
Why?
Antiviral Agents
3
2020
108
0.750
Why?
Clinical Clerkship
1
2021
42
0.750
Why?
Therapies, Investigational
1
2020
4
0.750
Why?
Adrenergic alpha-Agonists
2
2017
42
0.740
Why?
Inflammation
4
2019
530
0.740
Why?
Tattooing
2
2011
7
0.740
Why?
Specialization
6
2017
31
0.740
Why?
Plant Extracts
2
2018
61
0.740
Why?
Sleep
2
2013
92
0.730
Why?
Incidence
13
2021
1199
0.730
Why?
Anti-Infective Agents, Local
2
2020
15
0.730
Why?
Forehead
1
2020
13
0.730
Why?
Aerosols
2
2020
14
0.730
Why?
Phobic Disorders
1
2020
9
0.730
Why?
Immunotherapy
2
2018
81
0.720
Why?
Gentian Violet
1
2020
3
0.720
Why?
Professional Practice
3
2011
24
0.720
Why?
Medication Errors
4
2009
22
0.720
Why?
Warts
1
2020
3
0.710
Why?
Injections, Intralesional
1
2020
15
0.710
Why?
Back
1
2020
4
0.710
Why?
Social Conformity
1
2020
1
0.710
Why?
Baths
1
2020
8
0.710
Why?
Cultural Diversity
1
2020
22
0.700
Why?
Drug Delivery Systems
3
2020
104
0.700
Why?
Impetigo
2
2012
4
0.700
Why?
Affect
3
2011
70
0.690
Why?
Infant, Newborn
13
2020
672
0.690
Why?
Balsams
1
2019
1
0.690
Why?
Electrical Equipment and Supplies
1
2019
1
0.690
Why?
Job Application
1
2019
6
0.690
Why?
Pigmentation Disorders
3
2014
8
0.690
Why?
Books
1
2019
3
0.690
Why?
Alcoholic Beverages
1
2019
6
0.690
Why?
Neuralgia, Postherpetic
1
2019
6
0.690
Why?
Patient Care
3
2017
30
0.690
Why?
Safety Management
3
2010
37
0.690
Why?
Cost Savings
5
2013
34
0.680
Why?
North Carolina
23
2017
1538
0.680
Why?
Multivariate Analysis
14
2015
684
0.680
Why?
Leg Dermatoses
1
2019
2
0.680
Why?
Skin Diseases, Genetic
1
2019
4
0.680
Why?
Self Administration
3
2010
297
0.670
Why?
Patients
5
2013
46
0.660
Why?
Bonding, Human-Pet
1
2019
1
0.660
Why?
Veterinarians
1
2019
1
0.660
Why?
Injections, Subcutaneous
6
2019
35
0.660
Why?
Animal Husbandry
1
2019
7
0.660
Why?
Finger Joint
1
2019
12
0.650
Why?
Perception
5
2018
101
0.650
Why?
Skin Aging
1
2019
9
0.650
Why?
Family Practice
6
2015
51
0.650
Why?
Fish Oils
1
2019
36
0.650
Why?
Electrocoagulation
2
2016
12
0.650
Why?
Morgellons Disease
1
2018
3
0.650
Why?
Wound Infection
1
2018
10
0.650
Why?
Pharmacogenetics
1
2018
29
0.650
Why?
Fees and Charges
2
2016
14
0.650
Why?
Aortitis
1
2018
1
0.650
Why?
Economics, Pharmaceutical
4
2017
5
0.640
Why?
Whole-Body Irradiation
1
2019
53
0.640
Why?
Chronic Disease
12
2017
406
0.640
Why?
Benchmarking
4
2012
23
0.640
Why?
Income
2
2021
63
0.640
Why?
Antiretroviral Therapy, Highly Active
1
2018
29
0.640
Why?
Hepatitis B
1
2018
17
0.640
Why?
Antipsychotic Agents
1
2018
27
0.640
Why?
Central Nervous System Neoplasms
1
2019
29
0.640
Why?
Patient-Centered Care
2
2012
75
0.640
Why?
Public Opinion
2
2018
17
0.630
Why?
Adaptation, Psychological
2
2017
138
0.630
Why?
Sick Leave
1
2018
4
0.630
Why?
Education, Medical, Graduate
3
2015
127
0.630
Why?
Health Insurance Portability and Accountability Act
1
2018
5
0.630
Why?
Prescriptions
3
2015
12
0.630
Why?
Thyroid Neoplasms
1
2019
33
0.630
Why?
Cytokines
2
2017
256
0.620
Why?
Nails, Ingrown
2
2015
2
0.620
Why?
Emergency Service, Hospital
3
2016
474
0.620
Why?
Blood Donors
1
2018
14
0.620
Why?
Confidentiality
1
2018
29
0.620
Why?
Tinea
2
2016
4
0.620
Why?
Porphyrins
1
2018
29
0.620
Why?
Injections
5
2019
64
0.620
Why?
Health Services
2
2017
39
0.610
Why?
Porphyria Cutanea Tarda
1
2018
15
0.610
Why?
Candidiasis, Chronic Mucocutaneous
1
2017
1
0.610
Why?
Donor Selection
1
2018
33
0.610
Why?
Range of Motion, Articular
1
2019
187
0.610
Why?
International Cooperation
2
2020
28
0.610
Why?
Efficiency
4
2019
18
0.610
Why?
Drug Resistance
4
2018
38
0.600
Why?
Logistic Models
10
2015
783
0.600
Why?
Caloric Restriction
1
2019
106
0.590
Why?
Academic Medical Centers
5
2019
158
0.590
Why?
Janus Kinases
3
2016
4
0.590
Why?
Alopecia Areata
2
2015
16
0.590
Why?
Faculty, Medical
2
2010
78
0.590
Why?
Glioma
1
2019
136
0.590
Why?
Drug Approval
4
2019
10
0.590
Why?
Medical Errors
2
2010
36
0.580
Why?
Alcohol Drinking
2
2017
255
0.580
Why?
Nevus
2
2015
15
0.580
Why?
Photochemotherapy
2
2017
21
0.580
Why?
Agriculture
7
2013
189
0.580
Why?
Health Behavior
3
2015
236
0.580
Why?
Liver Neoplasms
1
2019
155
0.580
Why?
Receptors, Interleukin
1
2017
16
0.580
Why?
Staphylococcus aureus
2
2019
53
0.570
Why?
Facial Neoplasms
2
2008
9
0.570
Why?
Professional-Patient Relations
1
2017
25
0.570
Why?
Parents
3
2020
147
0.570
Why?
Sunlight
6
2019
17
0.570
Why?
Electrodes
2
2016
17
0.560
Why?
Cellulitis
1
2016
10
0.560
Why?
Residence Characteristics
2
2017
202
0.560
Why?
Cohort Studies
9
2018
1817
0.560
Why?
Abscess
1
2016
26
0.560
Why?
Outpatients
6
2016
57
0.560
Why?
Exanthema
1
2016
21
0.560
Why?
Software
2
2017
123
0.560
Why?
Online Systems
1
2016
12
0.550
Why?
Pyrazoles
2
2017
67
0.550
Why?
Zebrafish
1
2016
23
0.550
Why?
Diagnostic Errors
1
2016
43
0.550
Why?
Reproducibility of Results
11
2020
765
0.550
Why?
Biomimetic Materials
1
2016
15
0.550
Why?
Biopsy, Needle
2
2018
93
0.550
Why?
Health Care Rationing
2
2014
12
0.550
Why?
Electrosurgery
3
2014
5
0.540
Why?
Accidents, Traffic
1
2018
195
0.540
Why?
Skin Pigmentation
5
2014
26
0.540
Why?
Interpersonal Relations
4
2017
57
0.530
Why?
Cryotherapy
3
2012
13
0.530
Why?
Abnormalities, Drug-Induced
2
2006
3
0.530
Why?
African Americans
8
2017
1425
0.530
Why?
Medical Records
4
2013
76
0.530
Why?
Hydroquinones
4
2014
6
0.530
Why?
Naltrexone
2
2006
18
0.520
Why?
Empathy
2
2013
18
0.510
Why?
Mothers
2
2013
88
0.510
Why?
Body Surface Area
3
2017
15
0.510
Why?
Spondylitis, Ankylosing
1
2015
4
0.510
Why?
Occupational Diseases
6
2014
81
0.510
Why?
Teratoma
1
2015
10
0.510
Why?
Fee-for-Service Plans
1
2015
12
0.500
Why?
Etretinate
2
2013
2
0.500
Why?
European Continental Ancestry Group
9
2017
1166
0.500
Why?
Costs and Cost Analysis
5
2016
100
0.500
Why?
Diagnosis, Differential
7
2018
517
0.500
Why?
Precancerous Conditions
3
2011
27
0.500
Why?
Needs Assessment
3
2014
76
0.500
Why?
Disease Models, Animal
2
2016
1022
0.500
Why?
Physical Examination
3
2015
92
0.490
Why?
Urocanic Acid
1
2014
1
0.490
Why?
Splints
1
2014
13
0.490
Why?
Age Distribution
6
2020
206
0.490
Why?
Lipoxins
1
2014
2
0.490
Why?
Acrylates
1
2014
1
0.490
Why?
Onycholysis
1
2014
1
0.490
Why?
Clinical Trials, Phase II as Topic
3
2020
14
0.490
Why?
Arthritis
1
2015
40
0.490
Why?
Electronic Mail
2
2017
18
0.480
Why?
Social Desirability
1
2014
12
0.480
Why?
Parathyroid Neoplasms
1
2014
7
0.480
Why?
Surgical Wound Infection
2
2014
84
0.480
Why?
Antihypertensive Agents
1
2017
352
0.480
Why?
Medically Underserved Area
3
2013
23
0.480
Why?
Single-Blind Method
4
2020
203
0.480
Why?
Electronic Health Records
5
2018
162
0.480
Why?
Quality Indicators, Health Care
3
2015
59
0.480
Why?
Isoniazid
1
2014
4
0.480
Why?
Antitubercular Agents
1
2014
8
0.480
Why?
Lupus Erythematosus, Discoid
1
2014
7
0.480
Why?
Self Medication
2
2011
6
0.480
Why?
Excipients
1
2014
2
0.470
Why?
Erythromycin
1
2014
7
0.470
Why?
Rural Health Services
3
2009
30
0.470
Why?
Home Nursing
3
2010
10
0.470
Why?
Adenoma
1
2014
35
0.470
Why?
Contraceptives, Oral
2
2012
23
0.470
Why?
Head and Neck Neoplasms
3
2015
130
0.470
Why?
Anxiety
7
2021
191
0.470
Why?
Gynecomastia
1
2014
2
0.470
Why?
Webcasts as Topic
2
2012
3
0.460
Why?
Case-Control Studies
6
2020
898
0.460
Why?
Scurvy
1
2013
3
0.460
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2014
44
0.460
Why?
Hidradenitis Suppurativa
3
2019
9
0.460
Why?
Flutamide
1
2013
5
0.450
Why?
Hydroxy Acids
1
2013
2
0.450
Why?
Lupus Erythematosus, Systemic
2
2014
148
0.450
Why?
HIV Infections
1
2018
395
0.450
Why?
Folic Acid Deficiency
1
2013
2
0.450
Why?
Folic Acid Antagonists
1
2013
3
0.450
Why?
Antineoplastic Agents, Hormonal
1
2013
42
0.450
Why?
Herpes Labialis
1
2013
1
0.450
Why?
Drug Eruptions
1
2013
9
0.450
Why?
Transportation
1
2013
13
0.450
Why?
Folic Acid
1
2013
12
0.440
Why?
Drug Tolerance
1
2013
32
0.440
Why?
Physician Assistants
3
2010
41
0.440
Why?
Breast
1
2014
68
0.440
Why?
Clinical Competence
5
2015
333
0.440
Why?
Consensus
4
2020
85
0.440
Why?
Dermatomycoses
3
2009
7
0.440
Why?
Vitamin D Deficiency
1
2014
89
0.440
Why?
Socioeconomic Factors
6
2018
429
0.440
Why?
Health Surveys
8
2019
198
0.440
Why?
Nevus, Sebaceous of Jadassohn
1
2012
1
0.430
Why?
Mouth
1
2013
25
0.430
Why?
Signal Processing, Computer-Assisted
1
2013
38
0.430
Why?
Staphylococcal Skin Infections
1
2012
4
0.430
Why?
Disease Progression
4
2018
594
0.420
Why?
Health Services Research
3
2010
82
0.420
Why?
Patch Tests
4
2010
8
0.420
Why?
Decision Making
2
2019
195
0.420
Why?
Progestins
1
2012
22
0.420
Why?
Telephone
4
2018
59
0.420
Why?
Hydrocortisone
2
2011
57
0.410
Why?
Employment
2
2018
49
0.410
Why?
Antimetabolites
1
2012
11
0.410
Why?
Cosmetics
3
2010
11
0.410
Why?
Imaging, Three-Dimensional
1
2013
132
0.410
Why?
Arthrodermataceae
2
2009
3
0.410
Why?
Organ Transplantation
1
2012
66
0.400
Why?
Fluocinolone Acetonide
2
2012
5
0.400
Why?
Practice Management, Medical
2
2013
8
0.400
Why?
Choice Behavior
3
2019
87
0.400
Why?
Data Collection
6
2014
182
0.400
Why?
Drug Resistance, Bacterial
5
2014
47
0.390
Why?
Demyelinating Diseases
1
2011
10
0.390
Why?
Self Efficacy
3
2017
78
0.390
Why?
Self-Examination
1
2011
1
0.390
Why?
Image Processing, Computer-Assisted
1
2013
226
0.390
Why?
Health Status
3
2011
400
0.390
Why?
Propionibacterium acnes
4
2014
4
0.390
Why?
Pityriasis Rubra Pilaris
1
2011
1
0.390
Why?
Information Dissemination
2
2009
52
0.380
Why?
Foundations
2
2008
8
0.380
Why?
Regression Analysis
6
2017
293
0.380
Why?
Estrogens
1
2012
180
0.380
Why?
Molluscum Contagiosum
2
2015
3
0.380
Why?
Appointments and Schedules
2
2020
22
0.380
Why?
Zinc
2
2019
32
0.380
Why?
Computer Peripherals
1
2010
1
0.380
Why?
Friction
1
2010
4
0.380
Why?
Diet
1
2013
391
0.380
Why?
Odds Ratio
6
2017
472
0.380
Why?
Photosensitizing Agents
3
2010
24
0.370
Why?
Clotrimazole
3
2007
4
0.370
Why?
Educational Status
4
2020
181
0.370
Why?
Eyeglasses
1
2010
3
0.370
Why?
Antidepressive Agents
2
2014
74
0.370
Why?
Linear Models
4
2019
449
0.370
Why?
Chromium
1
2010
2
0.360
Why?
Nickel
1
2010
2
0.360
Why?
Risk-Taking
2
2009
96
0.360
Why?
Health Services Misuse
1
2010
7
0.360
Why?
Frozen Sections
1
2010
18
0.360
Why?
Pregnancy
9
2019
997
0.360
Why?
Desonide
1
2010
1
0.360
Why?
Pharmaceutical Services
1
2010
7
0.360
Why?
Life Style
1
2013
408
0.360
Why?
Vitamin E
1
2010
23
0.360
Why?
Publications
1
2010
9
0.360
Why?
Prospective Studies
7
2018
2283
0.360
Why?
Ear Cartilage
1
2010
12
0.350
Why?
Algorithms
6
2015
495
0.350
Why?
Medically Uninsured
1
2010
32
0.350
Why?
Patient Participation
2
2014
82
0.350
Why?
Antimetabolites, Antineoplastic
2
2014
49
0.350
Why?
Textiles
1
2009
1
0.350
Why?
Clothing
1
2009
6
0.350
Why?
Social Marketing
1
2010
15
0.350
Why?
Cartilage Diseases
1
2010
21
0.350
Why?
Financing, Personal
2
2014
6
0.350
Why?
Communicable Diseases
1
2009
20
0.340
Why?
Health Care Reform
1
2010
44
0.340
Why?
Cost Sharing
2
2006
10
0.340
Why?
Marketing
1
2010
37
0.340
Why?
Data Interpretation, Statistical
2
2013
109
0.340
Why?
Education, Medical
1
2010
69
0.340
Why?
Mandatory Reporting
3
2006
7
0.330
Why?
Dermatitis, Perioral
1
2009
1
0.330
Why?
Burnout, Professional
2
2021
51
0.330
Why?
General Surgery
3
2014
88
0.330
Why?
Risk Management
2
2006
27
0.330
Why?
Insurance Carriers
1
2009
18
0.330
Why?
Elastic Tissue
1
2009
2
0.330
Why?
Triage
2
2010
72
0.330
Why?
Radio Waves
1
2009
8
0.330
Why?
Physicians' Offices
3
2005
10
0.330
Why?
Narcotic Antagonists
2
2006
40
0.330
Why?
Sirolimus
1
2009
33
0.320
Why?
Neoplasms
3
2017
728
0.320
Why?
Pamphlets
2
2007
5
0.320
Why?
Language
3
2007
42
0.320
Why?
Social Support
3
2017
182
0.320
Why?
Mass Screening
3
2017
263
0.320
Why?
Placebos
3
2020
63
0.320
Why?
Diabetes Mellitus, Type 2
1
2017
1428
0.320
Why?
Fibromyalgia
1
2009
25
0.320
Why?
Fluocortolone
1
2008
1
0.310
Why?
Interleukin-12
2
2008
28
0.310
Why?
Guideline Adherence
3
2015
120
0.310
Why?
Internal Medicine
4
2015
54
0.310
Why?
Multicenter Studies as Topic
3
2019
105
0.310
Why?
Hand
2
2019
66
0.310
Why?
Crohn Disease
2
2019
26
0.310
Why?
Selection Bias
1
2008
13
0.310
Why?
Colitis, Ulcerative
2
2018
23
0.310
Why?
Occupational Exposure
5
2009
232
0.310
Why?
Safety
5
2011
77
0.300
Why?
Histamine Antagonists
3
2018
5
0.300
Why?
Healthcare Disparities
1
2010
169
0.300
Why?
Social Problems
1
2007
2
0.300
Why?
Interleukin-12 Subunit p40
1
2007
3
0.300
Why?
Internationality
1
2007
22
0.300
Why?
Quality-Adjusted Life Years
3
2017
31
0.300
Why?
Interviews as Topic
6
2017
266
0.290
Why?
Asian Continental Ancestry Group
3
2014
108
0.290
Why?
Episode of Care
2
2004
5
0.290
Why?
Sexually Transmitted Diseases
1
2008
44
0.290
Why?
Pregnancy Outcome
2
2018
90
0.290
Why?
Substance-Related Disorders
1
2008
128
0.290
Why?
Interleukins
2
2017
19
0.290
Why?
Absenteeism
3
2018
11
0.290
Why?
Skin Diseases, Vesiculobullous
1
2007
6
0.290
Why?
Career Choice
1
2007
43
0.280
Why?
Sleep Apnea Syndromes
2
2017
27
0.280
Why?
Forms and Records Control
1
2006
7
0.280
Why?
Fellowships and Scholarships
1
2007
52
0.280
Why?
Personality
3
2014
16
0.280
Why?
Electronics
1
2006
14
0.280
Why?
beta-Endorphin
1
2006
1
0.270
Why?
Tachyphylaxis
1
2006
1
0.270
Why?
Multiple Sclerosis
1
2007
59
0.270
Why?
Women
1
2006
12
0.270
Why?
Evaluation Studies as Topic
2
2016
44
0.260
Why?
Health Services for the Aged
2
2007
25
0.260
Why?
Seasons
4
2017
91
0.260
Why?
Surgicenters
2
2004
3
0.260
Why?
Anti-Allergic Agents
2
2017
6
0.260
Why?
Reconstructive Surgical Procedures
2
2007
198
0.260
Why?
Carcinoma
1
2006
91
0.260
Why?
Europe
3
2015
82
0.260
Why?
Insurance Benefits
1
2005
5
0.260
Why?
Acne Keloid
1
2005
2
0.260
Why?
Social Behavior
1
2006
65
0.260
Why?
Insurance Claim Review
2
2019
27
0.250
Why?
Narcotics
1
2005
16
0.250
Why?
Withholding Treatment
2
2018
11
0.250
Why?
Heliotherapy
1
2005
3
0.250
Why?
Complementary Therapies
2
2017
80
0.250
Why?
Sensitivity and Specificity
3
2013
582
0.250
Why?
Hospital Charges
1
2005
15
0.250
Why?
Tinea Pedis
2
2015
5
0.250
Why?
Relaxation
2
2019
9
0.250
Why?
Rheumatology
3
2020
9
0.250
Why?
Sex Distribution
3
2017
191
0.250
Why?
Fear
2
2019
48
0.250
Why?
Dietary Supplements
2
2019
185
0.230
Why?
Automobiles
2
2014
15
0.230
Why?
Age of Onset
3
2020
94
0.230
Why?
Lupus Erythematosus, Cutaneous
2
2018
13
0.230
Why?
Bioterrorism
1
2003
5
0.230
Why?
Meat-Packing Industry
2
2014
8
0.230
Why?
Early Diagnosis
2
2017
62
0.230
Why?
Itraconazole
1
2003
6
0.230
Why?
Disclosure
1
2003
31
0.220
Why?
Iran
2
2013
4
0.220
Why?
Organometallic Compounds
1
2003
23
0.220
Why?
Current Procedural Terminology
1
2003
3
0.220
Why?
Insurance Claim Reporting
1
2003
3
0.220
Why?
Pyridines
1
2003
76
0.220
Why?
Program Development
2
2018
97
0.220
Why?
Prognosis
6
2019
1497
0.220
Why?
Referral and Consultation
3
2011
142
0.220
Why?
Tonsillitis
1
2003
6
0.220
Why?
Occupational Health
3
2015
82
0.220
Why?
Directive Counseling
1
2002
18
0.210
Why?
Pregnancy Complications
2
2009
105
0.210
Why?
T-Lymphocytes
2
2014
124
0.210
Why?
Aminoquinolines
2
2015
16
0.210
Why?
Qualitative Research
3
2018
175
0.210
Why?
Demography
2
2020
110
0.210
Why?
Analysis of Variance
4
2020
464
0.210
Why?
Nausea
1
2002
53
0.210
Why?
Drugs, Investigational
2
2020
6
0.210
Why?
Hypnotics and Sedatives
1
2002
28
0.200
Why?
Diabetes Mellitus
3
2015
412
0.200
Why?
Staphylococcal Infections
1
2003
77
0.200
Why?
Food-Processing Industry
3
2013
40
0.200
Why?
Drug Administration Routes
3
2012
12
0.200
Why?
Equipment Design
3
2014
171
0.200
Why?
Emigrants and Immigrants
3
2014
244
0.200
Why?
Mice, Knockout
2
2017
443
0.200
Why?
Dosage Forms
2
2012
4
0.190
Why?
Solutions
2
2016
36
0.190
Why?
Diterpenes
1
2021
20
0.190
Why?
Psychometrics
4
2015
137
0.190
Why?
History, 21st Century
2
2020
59
0.190
Why?
Models, Econometric
2
2017
8
0.190
Why?
History, 20th Century
2
2020
71
0.190
Why?
Liver
2
2016
484
0.180
Why?
Organizations, Nonprofit
1
2020
6
0.180
Why?
Mental Disorders
1
2002
124
0.180
Why?
Mice
4
2017
2484
0.180
Why?
Societies, Medical
3
2019
164
0.180
Why?
Postoperative Care
2
2018
76
0.180
Why?
Lichen Sclerosus et Atrophicus
1
2020
9
0.180
Why?
Employee Retirement Income Security Act
1
2020
5
0.180
Why?
Education, Medical, Undergraduate
1
2021
86
0.180
Why?
Face
2
2017
29
0.180
Why?
Pharmacy
1
2020
2
0.180
Why?
Tuberculin
1
2020
1
0.180
Why?
Pain Measurement
3
2018
350
0.180
Why?
Republic of Korea
1
2020
12
0.180
Why?
Aminolevulinic Acid
1
2020
9
0.180
Why?
Steroids
1
2020
38
0.180
Why?
Japan
1
2020
17
0.180
Why?
Mycobacterium
1
2020
3
0.180
Why?
Bacterial Vaccines
1
2020
8
0.180
Why?
Interdisciplinary Communication
2
2013
58
0.180
Why?
Communicable Disease Control
1
2020
15
0.180
Why?
BCG Vaccine
1
2020
8
0.180
Why?
Journal Impact Factor
1
2020
11
0.180
Why?
Informed Consent
1
2020
34
0.180
Why?
China
1
2020
50
0.180
Why?
Drug Synergism
1
2020
66
0.180
Why?
Blood Cell Count
1
2020
29
0.170
Why?
Sampling Studies
3
2009
45
0.170
Why?
Interferon-alpha
1
2020
70
0.170
Why?
Metabolome
1
2020
36
0.170
Why?
Neurodermatitis
1
2019
3
0.170
Why?
Asthma
2
2015
259
0.170
Why?
Early Detection of Cancer
2
2019
93
0.170
Why?
Congresses as Topic
2
2012
41
0.170
Why?
Ficusin
3
2010
5
0.170
Why?
Thorax
1
2019
29
0.170
Why?
Authorship
1
2019
9
0.170
Why?
Unnecessary Procedures
1
2019
16
0.170
Why?
Statistics, Nonparametric
2
2010
130
0.170
Why?
Clinical Protocols
2
2011
97
0.170
Why?
Students, Medical
1
2021
131
0.170
Why?
Patient Care Team
2
2010
129
0.170
Why?
Women's Health
1
2021
235
0.170
Why?
Random Allocation
1
2020
228
0.170
Why?
Arm
1
2019
35
0.170
Why?
Herpes Zoster Vaccine
1
2019
4
0.170
Why?
Diet, Gluten-Free
1
2019
3
0.170
Why?
Selenium
1
2019
4
0.170
Why?
Malassezia
1
2019
1
0.170
Why?
Work Schedule Tolerance
1
2019
10
0.170
Why?
Herpes Zoster
1
2019
10
0.170
Why?
Periodontitis
1
2019
9
0.160
Why?
Croton
1
2018
2
0.160
Why?
Hyperhidrosis
1
2019
5
0.160
Why?
Candida albicans
1
2019
12
0.160
Why?
Paternal Exposure
1
2018
1
0.160
Why?
Streptococcus pyogenes
1
2019
16
0.160
Why?
Probiotics
1
2019
10
0.160
Why?
Glossitis, Benign Migratory
1
2018
2
0.160
Why?
Risperidone
1
2018
3
0.160
Why?
Databases as Topic
1
2018
22
0.160
Why?
Trifluoperazine
1
2018
4
0.160
Why?
Maternal Exposure
1
2018
10
0.160
Why?
Fatigue
2
2009
85
0.160
Why?
Population Surveillance
3
2010
125
0.160
Why?
CD4 Lymphocyte Count
1
2018
32
0.160
Why?
Virus Activation
1
2018
7
0.160
Why?
Immune Tolerance
1
2019
71
0.160
Why?
Primates
1
2019
108
0.160
Why?
Red Cross
1
2018
2
0.160
Why?
World Health Organization
1
2018
15
0.160
Why?
Skin Absorption
3
2009
9
0.160
Why?
Computer-Assisted Instruction
1
2018
23
0.160
Why?
Antiparasitic Agents
1
2018
6
0.160
Why?
Fees, Pharmaceutical
1
2018
2
0.150
Why?
Models, Organizational
1
2018
15
0.150
Why?
Expert Testimony
1
2018
11
0.150
Why?
Postoperative Complications
4
2014
780
0.150
Why?
Rhinophyma
1
2017
2
0.150
Why?
Adamantane
1
2017
3
0.150
Why?
Lidocaine
1
2018
18
0.150
Why?
Self-Help Groups
1
2017
10
0.150
Why?
Niacinamide
1
2017
8
0.150
Why?
Internal-External Control
1
2017
17
0.150
Why?
Epinephrine
1
2018
40
0.150
Why?
Keratinocytes
2
2015
29
0.150
Why?
Delivery of Health Care, Integrated
1
2018
32
0.150
Why?
Social Perception
1
2017
24
0.150
Why?
Information Services
2
2009
15
0.150
Why?
Genes, Essential
1
2017
4
0.150
Why?
Oropharyngeal Neoplasms
1
2017
18
0.150
Why?
Esophageal Neoplasms
1
2017
35
0.150
Why?
Gastrointestinal Diseases
1
2017
43
0.150
Why?
Pituitary-Adrenal System
1
2017
21
0.150
Why?
T-Lymphocytes, Cytotoxic
1
2017
37
0.150
Why?
Longitudinal Studies
7
2009
770
0.150
Why?
Videodisc Recording
1
2017
4
0.150
Why?
Markov Chains
1
2017
29
0.150
Why?
Tobacco
2
2008
57
0.140
Why?
Anesthetics, Local
1
2018
79
0.140
Why?
Substance Withdrawal Syndrome
2
2009
59
0.140
Why?
Coronary Disease
1
2018
211
0.140
Why?
Immunoglobulin E
1
2017
37
0.140
Why?
Patient Advocacy
2
2008
12
0.140
Why?
Lentigo
2
2008
4
0.140
Why?
Journalism, Medical
1
2016
1
0.140
Why?
Antineoplastic Agents
2
2014
608
0.140
Why?
African Continental Ancestry Group
4
2011
363
0.140
Why?
Quality Control
1
2016
44
0.130
Why?
Workers' Compensation
2
2006
3
0.130
Why?
Cattle
1
2016
103
0.130
Why?
Th2 Cells
1
2015
9
0.130
Why?
Minoxidil
1
2015
6
0.130
Why?
Interleukin-4
1
2015
22
0.130
Why?
Moving and Lifting Patients
1
2015
1
0.130
Why?
Interleukin-13
1
2015
28
0.130
Why?
Probability
4
2009
159
0.130
Why?
Electronic Prescribing
1
2015
2
0.130
Why?
Vasodilator Agents
1
2015
62
0.130
Why?
Antibodies
1
2015
52
0.130
Why?
Botulinum Toxins
1
2015
38
0.130
Why?
Florida
2
2005
37
0.130
Why?
Canada
2
2013
56
0.130
Why?
Health Education
2
2007
163
0.130
Why?
Emergency Medicine
1
2016
120
0.130
Why?
Ulcer
1
2014
3
0.120
Why?
Occlusive Dressings
1
2014
9
0.120
Why?
Radiotherapy
1
2015
82
0.120
Why?
Medical Informatics
2
2007
27
0.120
Why?
Suspensions
1
2014
2
0.120
Why?
Cyanoacrylates
1
2014
2
0.120
Why?
Hospital Costs
1
2015
38
0.120
Why?
Teaching
1
2015
63
0.120
Why?
Toes
1
2014
15
0.120
Why?
Musculoskeletal Diseases
1
2015
37
0.120
Why?
Oceanic Ancestry Group
1
2014
7
0.120
Why?
Thigh
1
2014
42
0.120
Why?
Antigens, CD19
1
2014
9
0.120
Why?
Immunotherapy, Adoptive
1
2014
12
0.120
Why?
Lymphoma, B-Cell
1
2014
11
0.120
Why?
Quinoxalines
1
2014
13
0.120
Why?
Receptors, Antigen, T-Cell
1
2014
27
0.120
Why?
Hypericum
1
2014
2
0.120
Why?
Herb-Drug Interactions
1
2014
2
0.120
Why?
Education, Medical, Continuing
3
2014
55
0.120
Why?
Minocycline
1
2014
11
0.120
Why?
Antibiotic Prophylaxis
1
2014
37
0.120
Why?
Lymphoma, Large B-Cell, Diffuse
1
2014
15
0.120
Why?
Pancytopenia
1
2014
3
0.120
Why?
Leukemia, Lymphoid
1
2014
3
0.120
Why?
Phosphodiesterase Inhibitors
1
2014
9
0.120
Why?
Resource Allocation
1
2014
9
0.120
Why?
Phosphoric Diester Hydrolases
1
2014
10
0.120
Why?
Single Person
1
2014
3
0.120
Why?
Unemployment
1
2014
4
0.120
Why?
Phytotherapy
1
2014
38
0.120
Why?
Medical Staff
1
2014
1
0.120
Why?
Tissue Distribution
1
2014
61
0.120
Why?
Drug Interactions
1
2014
78
0.120
Why?
Sarcomeres
1
2014
3
0.120
Why?
NADPH Dehydrogenase
1
2014
2
0.120
Why?
Cyclic AMP
1
2014
46
0.120
Why?
rho GTP-Binding Proteins
1
2014
10
0.120
Why?
Remission Induction
2
2005
84
0.120
Why?
Actigraphy
1
2014
13
0.120
Why?
Microtubule-Associated Proteins
1
2014
35
0.120
Why?
Health Personnel
1
2015
121
0.120
Why?
Mental Recall
1
2014
51
0.120
Why?
Polysomnography
1
2014
40
0.110
Why?
Microfilament Proteins
1
2014
31
0.110
Why?
Triamcinolone Acetonide
1
2013
4
0.110
Why?
Terminology as Topic
2
2005
65
0.110
Why?
Intracellular Signaling Peptides and Proteins
1
2014
73
0.110
Why?
Muscle Development
1
2014
49
0.110
Why?
Gasoline
1
2013
1
0.110
Why?
Lighting
1
2013
4
0.110
Why?
Biotechnology
1
2013
6
0.110
Why?
Drug Therapy, Computer-Assisted
1
2013
4
0.110
Why?
Feedback
1
2013
43
0.110
Why?
Valine
1
2013
14
0.110
Why?
Acyclovir
1
2013
14
0.110
Why?
Medical Waste Disposal
1
2013
2
0.110
Why?
Herpes Simplex
1
2013
13
0.110
Why?
Osteoporosis
1
2014
70
0.110
Why?
Keloid
1
2013
8
0.110
Why?
Needles
1
2013
31
0.110
Why?
Ketoconazole
1
2013
5
0.110
Why?
Dermatitis, Seborrheic
1
2013
4
0.110
Why?
Vitamins
1
2013
68
0.110
Why?
Equipment Failure Analysis
1
2013
42
0.110
Why?
International Classification of Diseases
1
2013
25
0.110
Why?
Carcinoma, Merkel Cell
1
2012
9
0.110
Why?
Sarcoma, Kaposi
1
2012
8
0.110
Why?
Otolaryngology
1
2013
17
0.110
Why?
Myocardium
1
2014
186
0.110
Why?
Culture
1
2012
41
0.110
Why?
Carcinoma in Situ
1
2012
15
0.110
Why?
Cumulative Trauma Disorders
1
2012
13
0.110
Why?
Fibroma
1
2012
10
0.100
Why?
Image Enhancement
1
2013
72
0.100
Why?
Housing
1
2013
65
0.100
Why?
Methylprednisolone
1
2012
12
0.100
Why?
Mexico
3
2007
71
0.100
Why?
Controlled Clinical Trials as Topic
2
2012
10
0.100
Why?
Fractures, Bone
1
2014
148
0.100
Why?
Attention Deficit Disorder with Hyperactivity
2
2018
36
0.100
Why?
Immunosuppression
1
2012
121
0.100
Why?
Proportional Hazards Models
1
2014
753
0.100
Why?
Confidence Intervals
2
2010
149
0.100
Why?
Hypercholesterolemia
1
2013
70
0.100
Why?
Liver Function Tests
1
2011
22
0.100
Why?
Puberty, Precocious
1
2011
1
0.100
Why?
Specialty Boards
1
2011
9
0.100
Why?
Horses
1
2011
15
0.100
Why?
Medicine, Traditional
2
2009
22
0.100
Why?
Disinfection
1
2011
5
0.100
Why?
Drugs, Chinese Herbal
1
2011
7
0.100
Why?
Milk
1
2011
16
0.100
Why?
Recurrence
2
2003
263
0.100
Why?
Wounds, Nonpenetrating
1
2012
88
0.100
Why?
Bandages
1
2011
33
0.100
Why?
Stress, Psychological
3
2009
221
0.100
Why?
Computer Terminals
1
2010
1
0.090
Why?
Latex Hypersensitivity
1
2010
1
0.090
Why?
Plasticizers
1
2010
2
0.090
Why?
Histamine H1 Antagonists
2
2008
9
0.090
Why?
Immunohistochemistry
1
2012
538
0.090
Why?
Neoplasms, Radiation-Induced
1
2010
13
0.090
Why?
Nurse Practitioners
1
2010
11
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
458
0.090
Why?
Carotid Stenosis
1
2011
58
0.090
Why?
Total Quality Management
1
2010
17
0.090
Why?
Waiting Lists
2
2007
34
0.090
Why?
Pathology, Clinical
1
2010
13
0.090
Why?
Aging
1
2017
946
0.090
Why?
Pennsylvania
2
2018
83
0.090
Why?
Time
1
2010
23
0.090
Why?
Durable Medical Equipment
1
2010
2
0.090
Why?
Ethics, Business
1
2010
2
0.090
Why?
Emigration and Immigration
2
2013
31
0.090
Why?
Smoking Cessation
1
2013
210
0.090
Why?
Conditioning, Classical
1
2010
26
0.090
Why?
Hygiene
2
2007
13
0.090
Why?
Hydroxides
1
2009
1
0.090
Why?
Mycology
1
2009
1
0.090
Why?
Potassium Compounds
1
2009
1
0.090
Why?
North Dakota
1
2009
3
0.090
Why?
Medical Audit
1
2009
16
0.090
Why?
Blood-Borne Pathogens
1
2009
8
0.090
Why?
Indicators and Reagents
1
2009
14
0.090
Why?
Specimen Handling
1
2009
33
0.090
Why?
Sample Size
2
2013
38
0.090
Why?
Dermatitis, Phototoxic
1
2009
2
0.080
Why?
Observer Variation
2
2020
105
0.080
Why?
Boston
1
2009
15
0.080
Why?
Deductibles and Coinsurance
1
2009
3
0.080
Why?
Sleep Apnea, Obstructive
1
2009
58
0.080
Why?
Beauty
1
2008
5
0.080
Why?
Rheumatic Diseases
1
2009
7
0.080
Why?
Neoplasms, Basal Cell
1
2008
2
0.080
Why?
Forecasting
3
2003
143
0.080
Why?
Signal Transduction
1
2012
682
0.080
Why?
Arthralgia
1
2009
33
0.080
Why?
Organizational Objectives
1
2008
23
0.080
Why?
Health Maintenance Organizations
2
2006
13
0.080
Why?
Adaptation, Physiological
1
2009
55
0.080
Why?
Electronics, Medical
1
2008
2
0.080
Why?
Microspheres
1
2008
44
0.080
Why?
Dermatitis, Irritant
1
2008
2
0.080
Why?
Sodium Hypochlorite
1
2008
3
0.080
Why?
Diagnostic Tests, Routine
1
2008
24
0.080
Why?
Detergents
1
2008
16
0.080
Why?
Acute Disease
2
2006
253
0.080
Why?
Eye Protective Devices
1
2008
6
0.080
Why?
Vision Disorders
1
2008
23
0.080
Why?
Tuberculin Test
1
2007
2
0.080
Why?
Radiotherapy Dosage
1
2008
101
0.080
Why?
Lichen Planus, Oral
1
2008
11
0.080
Why?
Parent-Child Relations
2
2010
46
0.080
Why?
Toxoplasmosis, Animal
1
2007
1
0.080
Why?
Leishmaniasis
1
2007
3
0.080
Why?
Receptors, Interleukin-12
1
2007
2
0.080
Why?
Injections, Intravenous
1
2007
78
0.070
Why?
Meta-Analysis as Topic
1
2007
43
0.070
Why?
Cryptococcosis
1
2007
5
0.070
Why?
Artifacts
1
2007
39
0.070
Why?
Drug Evaluation
2
2004
14
0.070
Why?
Behavior Therapy
1
2008
103
0.070
Why?
Prejudice
1
2007
50
0.070
Why?
Virus Diseases
1
2007
22
0.070
Why?
Ohio
1
2007
58
0.070
Why?
Communication Barriers
1
2007
22
0.070
Why?
Larva Migrans
1
2007
2
0.070
Why?
Bacterial Infections
1
2007
51
0.070
Why?
Drug Therapy
1
2007
16
0.070
Why?
Medical Staff, Hospital
1
2007
20
0.070
Why?
Microcomputers
1
2006
6
0.070
Why?
Models, Biological
1
2009
392
0.070
Why?
Chemistry, Pharmaceutical
1
2006
11
0.070
Why?
Predictive Value of Tests
1
2009
876
0.070
Why?
Focus Groups
2
2006
118
0.070
Why?
Vitamin A
1
2006
21
0.070
Why?
Lipectomy
2
2003
9
0.070
Why?
Hydroxyurea
1
2006
2
0.070
Why?
Eye Abnormalities
1
2006
4
0.070
Why?
Pterygium
1
2006
4
0.070
Why?
Social Adjustment
1
2006
9
0.070
Why?
Health Services Needs and Demand
1
2007
81
0.070
Why?
Radiation Dosage
2
2006
84
0.070
Why?
Skin Irritancy Tests
1
2005
1
0.070
Why?
Irritants
1
2005
2
0.070
Why?
Interferon-gamma
2
2017
57
0.070
Why?
Neoplasm Recurrence, Local
2
2008
367
0.070
Why?
Body Size
1
2005
34
0.070
Why?
Pleistophora
1
2005
1
0.070
Why?
Credentialing
1
2005
9
0.070
Why?
Dermatomyositis
1
2005
19
0.070
Why?
Drug Storage
1
2005
4
0.060
Why?
Candidiasis, Cutaneous
2
2002
2
0.060
Why?
Nicotine
1
2008
174
0.060
Why?
Poultry Products
1
2005
14
0.060
Why?
Child Health Services
1
2005
24
0.060
Why?
Respiratory Tract Diseases
1
2005
34
0.060
Why?
Educational Measurement
1
2006
123
0.060
Why?
Anesthesia
1
2005
64
0.060
Why?
Family Health
1
2005
78
0.060
Why?
Chemexfoliation
1
2004
2
0.060
Why?
Therapeutic Equivalency
1
2004
2
0.060
Why?
Texas
1
2004
36
0.060
Why?
Inpatients
1
2005
85
0.060
Why?
Reimbursement Mechanisms
1
2004
13
0.060
Why?
Urban Population
1
2005
90
0.060
Why?
Morbidity
1
2005
98
0.060
Why?
Hospital Mortality
1
2006
198
0.060
Why?
Primary Prevention
1
2004
54
0.060
Why?
Indians, North American
1
2004
109
0.060
Why?
Poultry
2
2014
27
0.060
Why?
Keratosis, Seborrheic
1
2003
1
0.060
Why?
Handwriting
1
2003
2
0.060
Why?
Disaster Planning
1
2003
27
0.060
Why?
State Government
1
2003
32
0.060
Why?
Medicare Part A
1
2003
5
0.060
Why?
Medicare Part B
1
2003
5
0.050
Why?
Rural Population
1
2005
277
0.050
Why?
Tonsillectomy
1
2003
11
0.050
Why?
Acrylic Resins
1
2002
2
0.050
Why?
Likelihood Functions
1
2002
48
0.050
Why?
Models, Psychological
1
2002
25
0.050
Why?
Drug Labeling
1
2002
3
0.050
Why?
Insurance, Health, Reimbursement
1
2002
15
0.050
Why?
Photosensitivity Disorders
1
2002
12
0.050
Why?
Feasibility Studies
1
2003
294
0.050
Why?
New York City
1
2002
14
0.050
Why?
Maryland
1
2002
28
0.050
Why?
Capitation Fee
1
2002
3
0.050
Why?
Tinea Versicolor
1
2002
1
0.050
Why?
California
1
2002
63
0.050
Why?
Migraine Disorders
1
2003
67
0.050
Why?
Body Mass Index
1
2005
923
0.050
Why?
Disability Evaluation
1
2003
240
0.050
Why?
Endpoint Determination
2
2013
20
0.050
Why?
Lasers
1
2002
21
0.050
Why?
Risk Reduction Behavior
1
2002
125
0.050
Why?
Asian Americans
1
2002
97
0.050
Why?
Preventive Health Services
1
2002
44
0.050
Why?
Disease-Free Survival
1
2002
317
0.050
Why?
Uncertainty
1
2021
10
0.050
Why?
Decision Support Techniques
1
2002
128
0.050
Why?
Visual Perception
1
2002
116
0.050
Why?
Disease Susceptibility
1
2021
57
0.050
Why?
Hypersensitivity
2
2014
24
0.050
Why?
Sleep Initiation and Maintenance Disorders
1
2021
54
0.050
Why?
Infectious Disease Medicine
1
2020
4
0.050
Why?
Epidemiology
1
2020
6
0.050
Why?
Propensity Score
1
2020
39
0.050
Why?
Advisory Committees
1
2020
31
0.050
Why?
Genitalia
1
2020
8
0.050
Why?
Delphi Technique
1
2020
40
0.050
Why?
Outpatient Clinics, Hospital
3
2007
16
0.050
Why?
Decontamination
1
2020
3
0.050
Why?
Equipment Reuse
1
2020
5
0.050
Why?
Telecommunications
1
2020
7
0.050
Why?
Virus Inactivation
1
2020
3
0.040
Why?
Masks
1
2020
5
0.040
Why?
Menopause
1
2021
95
0.040
Why?
Consensus Development Conferences as Topic
1
2020
10
0.040
Why?
Critical Care
1
2020
106
0.040
Why?
Iontophoresis
1
2019
6
0.040
Why?
Cholinergic Antagonists
1
2019
10
0.040
Why?
Skin Diseases, Bacterial
1
2018
3
0.040
Why?
Skin Diseases, Viral
1
2018
4
0.040
Why?
Sympathectomy
1
2019
21
0.040
Why?
Immunocompromised Host
1
2019
51
0.040
Why?
Coal Tar
2
2012
2
0.040
Why?
Commerce
1
2019
67
0.040
Why?
Interprofessional Relations
1
2019
48
0.040
Why?
New Jersey
1
2018
9
0.040
Why?
Half-Life
1
2018
23
0.040
Why?
Injections, Intradermal
1
2018
6
0.040
Why?
Antipruritics
1
2018
4
0.040
Why?
Anesthetics, Combined
1
2018
5
0.040
Why?
Anesthesia, Local
1
2018
16
0.040
Why?
Receptors, Opioid, kappa
1
2018
24
0.040
Why?
Janus Kinase 1
1
2017
5
0.040
Why?
Knowledge Bases
1
2017
3
0.040
Why?
Antigen Presentation
1
2017
9
0.040
Why?
Adoptive Transfer
1
2017
26
0.040
Why?
Vaccination
1
2019
138
0.040
Why?
Genome
1
2017
38
0.040
Why?
Histocompatibility Antigens Class I
1
2017
59
0.040
Why?
Smoking
2
2013
528
0.040
Why?
Area Under Curve
1
2016
93
0.030
Why?
Agrochemicals
2
2006
5
0.030
Why?
ROC Curve
1
2016
164
0.030
Why?
Pharmacies
1
2016
15
0.030
Why?
Sebum
1
2015
1
0.030
Why?
Sebaceous Glands
1
2015
2
0.030
Why?
Hair Follicle
1
2015
8
0.030
Why?
Nursing
1
2015
1
0.030
Why?
Blister
1
2015
7
0.030
Why?
Cell Line, Tumor
1
2017
726
0.030
Why?
Mutation
1
2017
489
0.030
Why?
Vidarabine
1
2014
6
0.030
Why?
Transplantation Conditioning
1
2014
13
0.030
Why?
Family
1
2015
117
0.030
Why?
Cyclophosphamide
1
2014
38
0.030
Why?
Neck
1
2014
27
0.030
Why?
Drug Utilization Review
2
2004
17
0.030
Why?
Azathioprine
1
2014
25
0.030
Why?
Equipment Safety
1
2014
20
0.030
Why?
Head
1
2014
51
0.030
Why?
Mycophenolic Acid
1
2014
41
0.030
Why?
Thiazolidines
1
2014
2
0.030
Why?
Actins
1
2014
51
0.030
Why?
Protein Isoforms
1
2014
57
0.030
Why?
Epidemiologic Studies
1
2013
20
0.030
Why?
Animals, Newborn
1
2014
114
0.030
Why?
Gene Expression Regulation, Developmental
1
2014
69
0.030
Why?
Environment
1
2013
54
0.030
Why?
Air Conditioning
1
2013
7
0.030
Why?
Humidity
1
2013
5
0.030
Why?
Myocytes, Cardiac
1
2014
86
0.030
Why?
RNA, Small Interfering
1
2014
114
0.030
Why?
Group Practice
1
2013
3
0.030
Why?
Private Practice
1
2013
4
0.030
Why?
Latin America
1
2013
9
0.030
Why?
Comparative Effectiveness Research
1
2012
25
0.030
Why?
Chickens
1
2012
38
0.030
Why?
Cell Differentiation
1
2014
469
0.020
Why?
Mice, Inbred C57BL
1
2014
767
0.020
Why?
Case Management
1
2011
5
0.020
Why?
Genetic Predisposition to Disease
1
2013
835
0.020
Why?
Reference Values
1
2010
246
0.020
Why?
Motivation
1
2010
113
0.020
Why?
Office Management
1
2007
2
0.020
Why?
Self Disclosure
1
2008
22
0.020
Why?
Time Management
1
2007
9
0.020
Why?
Hyperplasia
1
2007
41
0.020
Why?
Epidermis
1
2007
30
0.020
Why?
Leisure Activities
1
2007
14
0.020
Why?
Knowledge
1
2007
14
0.020
Why?
Minnesota
1
2006
22
0.020
Why?
Rural Health
1
2007
44
0.020
Why?
Rhode Island
1
2006
5
0.020
Why?
Insect Bites and Stings
1
2006
3
0.020
Why?
Plants
1
2006
7
0.020
Why?
Infusions, Intravenous
1
2006
100
0.020
Why?
Cross-Over Studies
1
2006
95
0.020
Why?
Cinnamates
1
2006
3
0.020
Why?
Chalcones
1
2006
3
0.020
Why?
Propiophenones
1
2006
4
0.020
Why?
Water
1
2006
56
0.020
Why?
Dose-Response Relationship, Radiation
1
2006
81
0.020
Why?
Workplace
1
2006
50
0.020
Why?
Sunburn
1
2005
2
0.020
Why?
Air Pollutants, Occupational
1
2005
4
0.020
Why?
Diagnosis-Related Groups
1
2005
11
0.020
Why?
Dermabrasion
1
2004
2
0.020
Why?
Teratogens
1
2004
2
0.020
Why?
Writing
1
2004
13
0.010
Why?
Statistics as Topic
1
2004
108
0.010
Why?
Comprehension
1
2003
19
0.010
Why?
Dihydroxycholecalciferols
1
2003
1
0.010
Why?
Anthralin
1
2003
2
0.010
Why?
Survival Rate
1
2005
877
0.010
Why?
Long-Term Care
1
2003
25
0.010
Why?
Diaper Rash
1
2002
1
0.010
Why?
Postoperative Period
1
2002
97
0.010
Why?
Time and Motion Studies
1
2002
6
0.010
Why?
Feldman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (1170)
Explore
_
Co-Authors (34)
Explore
_
Similar People (51)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_